EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study



Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study



American Journal of Cardiology 61(13): 1024-1030



Induction of ventricular tachycardia (VT) at electrophysiologic study in patients taking amiodarone poorly predicts recurrence of VT. Consequently, a discriminant function was developed (using parameters based on retrospective data) that appeared to identify high-risk patients. These parameters included ventricular effective refractory period, corrected QT interval, initiation of a repetitive ventricular response and the mode of VT induction. In the present study these parameters were prospectively evaluated in 60 patients with coronary artery disease and sustained VT or ventricular fibrillation (VF), in whom VT was still induced at electrophysiologic study during amiodarone therapy. Thirteen patients had recurrent events (sudden death in 8 patients had sustained VT in 5) and 47 patients had no symptomatic arrhythmia recurrence (follow up for 16 .+-. 2 months, mean .+-. standard error of the mean). The ventricular effective refractory period, corrected QT interval and presence of a repetitive ventricular response did not discriminate between patients with and without symptomatic arrhythmia recurrence. However, an easier mode of VT induction during amiodarone therapy versus control was highly predictive of arrhythmia recurrence: 9 of 13 (69%) recurrences were in this group. In contrast, only 4 of 44 (9%) patients who had either the same or harder mode of VT induction had a recurrent event. Overall, 9 of 16 (56%) patients with an easier mode of VT induction had a recurrence, including 6 of 8 patients with subsequent sudden cardiac death. It is concluded that electrophysiologic testing during amiodarone therapy is useful to identify high-risk patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 006205970

Download citation: RISBibTeXText

PMID: 3364357

DOI: 10.1016/0002-9149(88)90119-1



Related references

Electrophysiologic studies in patients with nonsustained ventricular tachycardia and coronary artery disease relation of left ventricular aneurysm to inducible tachycardia and prognosis. Clinical Research 34(1): 9A, 1986

Electrophysiologic testing and nonsustained ventricular tachycardia final report of a prospective study in patients with coronary artery disease and impaired ventricular function. Circulation 84(4 SUPPL 2): II21, 1991

Limited predictive value of inducible sustained ventricular tachycardia for future occurrence of spontaneous ventricular tachycardia in patients with coronary artery disease and relatively preserved cardiac function. Journal of Electrocardiology 36(3): 205-211, July, 2003

Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia. American Journal of Cardiology 70(6): 598-604, 1992

Intravenous amiodarone for recurrent polymorphic ventricular tachycardia and ventricular fibrillation related to acute myocardial infarction or coronary artery bypass surgery. Circulation 90(4 PART 2): I545, 1994

Role of electrophysiologic testing in patients with asymptomatic nonsustained ventricular tachycardia relationship to ventricular function and the presence or absence of coronary artery disease. Journal of the American College of Cardiology 13(2 SUPPL A): 19A, 1989

Electrophysiologic studies in patients with nonsustained ventricular tachycardia and coronary disease relation of ventricular aneurysm to inducible and prognosis. Journal of the American College of Cardiology 7(2 SUPPL A): 71A, 1986

Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands. Journal of the American College of Cardiology 16(3): 521-530, 1990

Nonsustained ventricular tachycardia in coronary artery disease: Relation to inducible sustained ventricular tachycardia. Annals of Internal Medicine 125(1): 35-39, 1996

Heart rate variability profiles in symptomatic coronary artery disease and preserved left ventricular function: relation to ventricular tachycardia and transient myocardial ischemia. Regression Growth Evaluation Statin Study (REGRESS). American Heart Journal 130(5): 1020-1025, 1995

Results of electrophysiologically guided operations for drug-resistant recurrent ventricular tachycardia and ventricular fibrillation due to coronary artery disease. Journal of Thoracic and Cardiovascular Surgery 87(3): 431-438, 1984

Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. American Journal of Cardiology 65(11): 722-728, 1990

Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. American Journal of Cardiology 63(15): 1052-1057, 1989

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. Journal of the American College of Cardiology 13(2): 442-449, 1989

Clinical course and prognostic value of ventricular tachycardia or ventricular fibrillation in patients without coronary artery disease. Zeitschrift fuer Kardiologie 78(8): 500-509, 1989